Researchers identify barriers to applying international breast cancer guidelines in MENA region
Can't see this email? View it online
   
  December 6, 2017  
  Breast Cancer  
  The latest breast cancer news from News Medical  
 Researchers identify barriers to applying international breast cancer guidelines in MENA regionResearchers identify barriers to applying international breast cancer guidelines in MENA region
 
Researchers surveying breast cancer management in the Middle East and North Africa region have identified significant barriers to applying international guidelines in this area, and are calling for localized best practice.
 
 
 Researchers unlock genetic processes underlying cancerResearchers unlock genetic processes underlying cancer
 
For many, breast cancer is more than just a disease – it's personal. One in eight women will be diagnosed with breast cancer at some point in their lives. But through new discoveries at the genetic level, the personal nature of cancer will eventually be what helps to beat it.
 
   New vaccine technique can effectively combat breast cancer, mice study showsNew vaccine technique can effectively combat breast cancer, mice study shows
 
A new vaccine technique can fight a certain type of breast cancer in mice. So-called HER2-positive breast cancer accounts for between 20 and 30 per cent of all cases of breast cancer in humans.
 
   Physicians' experiences with patients, family linked to breast cancer screening recommendationsPhysicians' experiences with patients, family linked to breast cancer screening recommendations
 
Results of a national survey of more than 800 physicians suggest that their experiences with patients, family members and friends with breast cancer are linked with their recommendations for routine mammograms.
 
   Study shows possibility to have breaks in medication against hormone-sensitive breast cancerStudy shows possibility to have breaks in medication against hormone-sensitive breast cancer
 
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer - without the effect of the treatment appearing to have been influenced. Women also feel better if they take a three-month break from the hormone treatment each year, according to a medication study reported in The Lancet.
 
 Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survival
 
Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survivalThree new articles present trends in survival for patients with ovarian, colon, and breast cancer in the United States by race and stage. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings reveal large, consistent, and persistent racial disparities in survival.
 
 
 Scientists investigate new role of old protein in breast cancer
 
Scientists investigate new role of old protein in breast cancerScientists led by Dr Chris Toseland of the University's School of Biosciences studied a protein called Myosin VI, a molecular motor which acts as a courier to transport other proteins within our cells.
 
 
 Dangling a carrot for patients to take healthy steps: Does it work?
 
Patricia Alexander knew she needed a mammogram but just couldn't find the time. "Every time I made an appointment, something would come up," said Alexander, 53, who lives in Moreno Valley, Calif.
 
 
 Bisphenol A (BPA) Health Effects
 
Bisphenol A (BPA) Health EffectsBisphenol A (BPA) is used as a plasticizer in polycarbonate plastic and epoxy resin production. In addition, it is used as an additive agent in the fabrication process of polyvinyl chloride (PVC) as well as in manufacturing healthcare machines, contact lenses, toys, window foils, and storage media.
 
 
 FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers
 
FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancersThe U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
 
 
 DNA sequencing could identify genetic cause of kidney disease
 
DNA sequencing could identify genetic cause of kidney diseaseDNA sequencing could soon become part of the routine diagnostic workup for patients with chronic kidney disease, suggests a new study from Columbia University Medical Center.